Add Company
Join Now

Oncotelic Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Oncotelic's estimated annual revenue is currently $3.7M per year.(i)
  • Oncotelic's estimated revenue per employee is $155,000

Employee Data

  • Oncotelic has 24 Employees.(i)
  • Oncotelic grew their employee count by 9% last year.

Oncotelic's People

NameTitleEmail/Phone
1
Chairman & CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
CMOReveal Email/Phone
4
Chief Clinical Officer-Translational MedicineReveal Email/Phone
5
SVP BiometricsReveal Email/Phone
6
Product ManagerReveal Email/Phone
7
Manager Webapp DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Oncotelic?

Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M24-25%N/A
#2
$2.5M2519%N/A
#3
$4.1M26-4%N/A
#4
$3.8M264%N/A
#5
$3.9M27-4%N/A